Literature DB >> 27880973

Immunopathogenesis of systemic lupus erythematosus and rheumatoid arthritis: the role of aberrant expression of non-coding RNAs in T cells.

N-S Lai1,2, M Koo3,4, C-L Yu5, M-C Lu1,2.   

Abstract

Non-coding RNAs (ncRNAs), including microRNAs (miRNAs) and long non-coding RNAs (lncRNAs), are RNA molecules that do not translate into protein. Both miRNAs and lncRNAs are known to regulate gene expression and to play an essential role in T cell differentiation and function. Both systemic lupus erythematosus (SLE), a prototypic systemic autoimmune disease, and rheumatoid arthritis (RA), a representative disease of inflammatory arthritis, are characterized by a complex dysfunction in the innate and adaptive immunity. T cells play a central role in cell-mediated immune response and multiple defects in T cells from patients with SLE and RA have been observed. Abnormality in T cell signalling, cytokine and chemokine production, T cell activation and apoptosis, T cell differentiation and DNA methylation that are associated closely with the aberrant expression of a number of miRNAs and lncRNAs have been implicated in the immunopathogenesis of SLE and RA. This review aims to provide an overview of the current state of research on the abnormal expression of miRNAs and lncRNAs in T cells and their roles in the immunopathogenesis of SLE and RA. In addition, by comparing the differences in aberrant expression of miRNAs and lncRNAs in T cells between patients with SLE and RA, controversial areas are highlighted that warrant further investigation.
© 2016 British Society for Immunology.

Entities:  

Keywords:  T lymphocytes; non-coding RNAs; rheumatoid arthritis; systemic lupus erythematosus

Mesh:

Substances:

Year:  2017        PMID: 27880973      PMCID: PMC5290235          DOI: 10.1111/cei.12903

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  87 in total

1.  Mycophenolic acid upregulates miR-142-3P/5P and miR-146a in lupus CD4+T cells.

Authors:  Q Tang; Y Yang; M Zhao; G Liang; H Wu; Q Liu; Y Xie; D Li; Y Dai; S Yung; T M Chan; Q Lu
Journal:  Lupus       Date:  2015-02-06       Impact factor: 2.911

2.  The expression and significance of miR-17-92 cluster miRs in CD4+ T cells from patients with systemic lupus erythematosus.

Authors:  Hai Hong Qin; Xiao Hua Zhu; Jun Liang; Jin Feng Wu; Yong Sheng Yang; Jin Hua Xu
Journal:  Clin Exp Rheumatol       Date:  2013-02-22       Impact factor: 4.473

3.  NF-kappaB-dependent induction of microRNA miR-146, an inhibitor targeted to signaling proteins of innate immune responses.

Authors:  Konstantin D Taganov; Mark P Boldin; Kuang-Jung Chang; David Baltimore
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-02       Impact factor: 11.205

Review 4.  Evidence that cytokines play a role in rheumatoid arthritis.

Authors:  Fionula M Brennan; Iain B McInnes
Journal:  J Clin Invest       Date:  2008-11       Impact factor: 14.808

5.  Increased expression of long noncoding RNAs LOC100652951 and LOC100506036 in T cells from patients with rheumatoid arthritis facilitates the inflammatory responses.

Authors:  Ming-Chi Lu; Hui-Chun Yu; Chia-Li Yu; Hsien-Bin Huang; Malcolm Koo; Chien-Hsueh Tung; Ning-Sheng Lai
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

6.  Altered microRNA expression profile with miR-146a upregulation in CD4+ T cells from patients with rheumatoid arthritis.

Authors:  Jingyi Li; Ying Wan; Qiuye Guo; Liyun Zou; Jinyu Zhang; Yongfei Fang; Jingbo Zhang; Jinjun Zhang; Xiaolan Fu; Hongli Liu; Liwei Lu; Yuzhang Wu
Journal:  Arthritis Res Ther       Date:  2010-05-11       Impact factor: 5.156

7.  PBMC and exosome-derived Hotair is a critical regulator and potent marker for rheumatoid arthritis.

Authors:  Jinsoo Song; Dongkyun Kim; Jiyeon Han; Yunha Kim; Myeungsu Lee; Eun-Jung Jin
Journal:  Clin Exp Med       Date:  2014-04-11       Impact factor: 3.984

8.  MicroRNA-146A contributes to abnormal activation of the type I interferon pathway in human lupus by targeting the key signaling proteins.

Authors:  Yuanjia Tang; Xiaobing Luo; Huijuan Cui; Xuming Ni; Min Yuan; Yanzhi Guo; Xinfang Huang; Haibo Zhou; Niek de Vries; Paul Peter Tak; Shunle Chen; Nan Shen
Journal:  Arthritis Rheum       Date:  2009-04

9.  MiR-125a targets effector programs to stabilize Treg-mediated immune homeostasis.

Authors:  Wen Pan; Shu Zhu; Dai Dai; Zheng Liu; Dan Li; Bin Li; Nicola Gagliani; Yunjiang Zheng; Yuanjia Tang; Matthew T Weirauch; Xiaoting Chen; Wei Zhu; Yue Wang; Bo Chen; Youcun Qian; Yingxuan Chen; Jingyuan Fang; Ronald Herbst; Laura Richman; Bahija Jallal; John B Harley; Richard A Flavell; Yihong Yao; Nan Shen
Journal:  Nat Commun       Date:  2015-05-12       Impact factor: 17.694

10.  Leucocyte subset-specific type 1 interferon signatures in SLE and other immune-mediated diseases.

Authors:  Shaun M Flint; Vojislav Jovanovic; Boon Wee Teo; Anselm Mak; Julian Thumboo; Eoin F McKinney; James C Lee; Paul MacAry; David M Kemeny; David Rw Jayne; Kok Yong Fong; Paul A Lyons; Kenneth Gc Smith
Journal:  RMD Open       Date:  2016-05-16
View more
  16 in total

Review 1.  Role of the innate and adaptive immune responses in the pathogenesis of systemic lupus erythematosus.

Authors:  Nasim Bolouri; Maryam Akhtari; Elham Farhadi; Reza Mansouri; Seyedeh Tahereh Faezi; Ahmadreza Jamshidi; Mahdi Mahmoudi
Journal:  Inflamm Res       Date:  2022-03-17       Impact factor: 4.575

Review 2.  Universal or Personalized Mesenchymal Stem Cell Therapies: Impact of Age, Sex, and Biological Source.

Authors:  Diana M Carp; Yun Liang
Journal:  Cells       Date:  2022-06-30       Impact factor: 7.666

3.  MicroRNA-126 deficiency enhanced the activation and function of CD4+ T cells by elevating IRS-1 pathway.

Authors:  F Chu; Y Hu; Y Zhou; M Guo; J Lu; W Zheng; H Xu; J Zhao; L Xu
Journal:  Clin Exp Immunol       Date:  2017-10-30       Impact factor: 4.330

4.  In Vivo PET Imaging of the Activated Immune Environment in a Small Animal Model of Inflammatory Arthritis.

Authors:  Benjamin L Franc; Sam Goth; John MacKenzie; Xiaojuan Li; Joseph Blecha; Tina Lam; Salma Jivan; Randall A Hawkins; Henry VanBrocklin
Journal:  Mol Imaging       Date:  2017-01-01       Impact factor: 4.488

5.  Long noncoding RNA profiling revealed differentially expressed lncRNAs associated with disease activity in PBMCs from patients with rheumatoid arthritis.

Authors:  Min Yuan; Shujun Wang; Lijie Yu; Bo Qu; Liming Xu; Lining Liu; Huanxia Sun; Chunxian Li; Yanjun Shi; Huaxiang Liu
Journal:  PLoS One       Date:  2017-11-15       Impact factor: 3.240

6.  Altered levels of immune-regulatory microRNAs in plasma samples of patients with lupus nephritis.

Authors:  Sepideh Zununi Vahed; Mohammadreza Nakhjavani; Jalal Etemadi; Henghame Jamshidi; Nima Jadidian; Tala Pourlak; Sima Abediazar
Journal:  Bioimpacts       Date:  2018-04-14

Review 7.  The function of ncRNAs in rheumatic diseases.

Authors:  Weilin Chen; Di Liu; Quan-Zhen Li; Honglin Zhu
Journal:  Epigenomics       Date:  2019-06-07       Impact factor: 4.778

Review 8.  Molecular and Cellular Bases of Immunosenescence, Inflammation, and Cardiovascular Complications Mimicking "Inflammaging" in Patients with Systemic Lupus Erythematosus.

Authors:  Chang-Youh Tsai; Chieh-Yu Shen; Hsien-Tzung Liao; Ko-Jen Li; Hui-Ting Lee; Cheng-Shiun Lu; Cheng-Han Wu; Yu-Min Kuo; Song-Chou Hsieh; Chia-Li Yu
Journal:  Int J Mol Sci       Date:  2019-08-09       Impact factor: 5.923

9.  The role of aberrant expression of T cell miRNAs affected by TNF-α in the immunopathogenesis of rheumatoid arthritis.

Authors:  Ning-Sheng Lai; Hui-Chun Yu; Chien-Hsueh Tung; Kuang-Yung Huang; Hsien-Bin Huang; Ming-Chi Lu
Journal:  Arthritis Res Ther       Date:  2017-12-01       Impact factor: 5.156

10.  Long Non-coding RNA HIX003209 Promotes Inflammation by Sponging miR-6089 via TLR4/NF-κB Signaling Pathway in Rheumatoid Arthritis.

Authors:  Shushan Yan; Pingping Wang; Jinghua Wang; Jinghan Yang; Hongying Lu; Chengwen Jin; Min Cheng; Donghua Xu
Journal:  Front Immunol       Date:  2019-09-18       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.